These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Value of histiocyte detection in Pap smears for predicting endometrial pathology. An institutional experience. Nassar A, Fleisher SR, Nasuti JF. Acta Cytol; 2003; 47(5):762-7. PubMed ID: 14526675 [Abstract] [Full Text] [Related]
27. [Is it possible to screen for endometrial carcinoma? Incidence and risk factors]. Broso PR, Giradi F. Minerva Ginecol; 1995 Dec; 47(12):539-52. PubMed ID: 8720976 [Abstract] [Full Text] [Related]
28. Detection of endometrial carcinoma and hyperplasia in asymptomatic women. Koss LG, Schreiber K, Oberlander SG, Moussouris HF, Lesser M. Obstet Gynecol; 1984 Jul; 64(1):1-11. PubMed ID: 6738931 [Abstract] [Full Text] [Related]
31. Glandular cell atypia on Papanicolaou smears: interobserver variability in the diagnosis and prediction of cell of origin. Simsir A, Hwang S, Cangiarella J, Elgert P, Levine P, Sheffield MV, Roberson J, Talley L, Chhieng DC. Cancer; 2003 Dec 25; 99(6):323-30. PubMed ID: 14681938 [Abstract] [Full Text] [Related]
32. Uterine body cancer mass screening at Tokai University Hospital. Nagase E, Yasuda M, Kajiwara H, Osamura RY, Yoshitake T, Hirasawa T, Muramatsu T, Miyamoto T, Murakami M, Makino T, Ogawa T. Tokai J Exp Clin Med; 2004 Jun 25; 29(2):43-8. PubMed ID: 15473339 [Abstract] [Full Text] [Related]
33. Cytohistologic correlation in patients with clinical symptoms of postmenopausal bleeding. Webster SD, Cason Z, Lemos LB, Benghuzzi H. Biomed Sci Instrum; 2000 Jun 25; 36():367-72. PubMed ID: 10834260 [Abstract] [Full Text] [Related]
34. Liquid-based endometrial cytology: cyto-histological correlation in a population of 917 women. Buccoliero AM, Gheri CF, Castiglione F, Garbini F, Barbetti A, Fambrini M, Bargelli G, Pappalardo S, Taddei A, Boddi V, Scarselli GF, Marchionni M, Taddei GL. Cytopathology; 2007 Aug 25; 18(4):241-9. PubMed ID: 17559564 [Abstract] [Full Text] [Related]
35. A case of microglandular adenocarcinoma of the endometrium. Karateke A, Haliloglu B, Atay V, Gurbuz A, Kir G. Gynecol Oncol; 2005 Dec 25; 99(3):778-81. PubMed ID: 16229880 [Abstract] [Full Text] [Related]
36. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma. Sutter C, Dallenbach-Hellweg G, Schmidt D, Baehring J, Bielau S, von Knebel Doeberitz M, Gebert J. Int J Gynecol Pathol; 2004 Jan 25; 23(1):18-25. PubMed ID: 14668545 [Abstract] [Full Text] [Related]
37. Clinical experience with a new endometrial cell sampling kit (Isaacs curity endometrium cell sampler) in the early detection of endometrial cancer. Feichter GE, Tauber PF, Landowski J. Acta Cytol; 1982 Jan 25; 26(2):141-3. PubMed ID: 6952714 [Abstract] [Full Text] [Related]
38. Endometrial cells and the AutoPap System for primary screening of cervicovaginal Pap smears. Walts AE, Thomas P. Diagn Cytopathol; 2002 Oct 25; 27(4):232-7. PubMed ID: 12357502 [Abstract] [Full Text] [Related]
39. Endocyte endometrial smears in the cytodiagnosis of endometrial carcinoma. Byrne AJ. Acta Cytol; 1990 Oct 25; 34(3):373-81. PubMed ID: 2343695 [Abstract] [Full Text] [Related]
40. [Pay attention to screening of endometrial carcinoma]. Wei LH. Zhonghua Fu Chan Ke Za Zhi; 2013 Dec 25; 48(12):881-3. PubMed ID: 24495677 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]